Grey Wolf Animal Health CorpTSXV:WOLF
- LAST PRICE0.7500
- TODAY'S CHANGE (%)0.0200 (2.7397%)
- Bid / Lots0.7300/ 44
- Ask / Lots0.8400/ 2
- Open / Previous Close0.7400 / 0.7300
- Day Range
- 52 Week Range
- Volume220,421
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | WOLF |
|---|---|---|
| 02:54 ET | 3000 | 0.73 |
| 03:12 ET | 217000 | 0.75 |
Apr 11, 2024
GREY WOLF ANIMAL HEALTH REPORTS FOURTH QUARTER AND YEAR END 2023 FINANCIAL RESULTS, from 5:00PM ET on Thursday Apr 11, 2024 by Dow Jones
5:00PM ET on Thursday Apr 11, 2024 by Dow JonesPress Release: GREY WOLF ANIMAL HEALTH REPORTS FOURTH QUARTER AND YEAR END 2023 FINANCIAL RESULTS, from 5:00PM ET on Thursday Apr 11, 2024 by Dow Jones
5:00PM ET on Thursday Apr 11, 2024 by Dow Jones
Apr 2, 2024
GREY WOLF ANIMAL HEALTH TO PRESENT AT THE 2024 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE, from 5:00PM ET on Tuesday Apr 02, 2024 by Dow Jones
5:00PM ET on Tuesday Apr 02, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Grey Wolf Animal Health Corp | 23.3M | 38.2x | --- |
Optimi Health Corp | 30.3M | -5.6x | --- |
Automotive Finco Corp | 14.7M | 10.5x | --- |
Delota Corp | 4.1M | -3.1x | --- |
Psyched Wellness Ltd | 11.6M | -2.3x | --- |
Vibe Growth Corp | 2.2M | -0.2x | --- |
Company Information
Grey Wolf Animal Health Corp. is a Canada-based animal health and wellness company. It has a portfolio of products that meets the unmet needs of veterinarians, clinics, and pets. Its segments include the animal health business unit and the pharmacy business unit. The animal health business unit segment primarily focuses on selling, marketing, and distributing pharmaceutical, nutraceutical and consumable products to veterinary clinics across Canada. The pharmacy business unit segment compounds pharmaceuticals, primarily for equine use but also for the bioidentical hormone replacement therapy market, all based on prescriptions received from veterinarians, physicians, and patients. Its product categories include companion animals and equine health. The companion animals product category includes wound care, nutraceuticals, and others. It focuses on in-licensing, acquiring, or developing prescription and non-prescription products for commercialization in the veterinarian channel in Canada.
Contact Information
- Headquarters
- 65 Front Street East, Suite 201Toronto, ON, Canada M5E 1B5
- Phone
- 416-481-2222
- Fax
- ---
Executives
- Chief Executive Officer, Secretary
- Angela Cechetto
- Founder, Director, Chief Veterinary Medical Officer
- Ian Sandler
- Chief Financial Officer
- Kevin Palmer
- Chief Commercial Officer
- Murray Roach
- Director
- Shawn Aspden
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $23.3M |
|---|---|
Revenue (TTM) | $25.4M |
Shares Outstanding | 31.0M |
Grey Wolf Animal Health Corp does not pay a dividend. | |
Beta | --- |
EPS | $0.02 |
Book Value | $0.81 |
P/E Ratio | 38.2x |
Price/Sales (TTM) | 0.9 |
Price/Cash Flow (TTM) | 11.3x |
Operating Margin | 6.12% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
